Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12879-018-3113-x http://scihub22266oqcxt.onion/10.1186/s12879-018-3113-x C5934808!5934808!29724184     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       BMC+Infect+Dis 2018 ; 18 (ä): ä Nephropedia Template TP {{tp|p=29724184|t=2018. High mortality in patients with Mycobacterium avium complex lung disease: a systematic review |pdf=|usr=}}{{29724184}} gab.com Text High mortality in patients with Mycobacterium avium complex lung disease: a systematic review JO: BMC Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=29724184 #FOAvip Background: The incidence of nontuberculous mycobacterial (NTM) pulmonary disease caused by Mycobacterium avium complex (MAC) in apparently immune-competent people is increasing worldwide. We performed a systematic review of the published literature on five-year all-cause mortality in patients with MAC lung disease, and pooled the mortality rates to give an overall estimate of five-year mortality from these studies. Methods: We systematically reviewed the literature up to 1st August 2017 using PubMedŽ and ProQuest Dialog? to search MedlineŽ and EmbaseŽ databases, respectively. Eligible studies contained >?10 patients with MAC, and numerical five-year mortality data or a treatment evaluation for this patient group. Mortality data were extracted and analysed to determine a pooled estimate of all-cause mortality. Results: Fourteen of 1035 identified studies, comprising 17 data sets with data from a total of 9035 patients, were eligible. The pooled estimate of five-year all-cause mortality was 27% (95% CI 21.3?37.8%). A high degree of heterogeneity was observed (I2 =?96%). The mortality in the data sets varied between 10 and 48%. Studies predominantly including patients with cavitary disease or greater comorbidity reported a higher risk of death. Patients in Asian studies tended to have a lower mortality risk. Predictors of mortality consistent across studies included male sex, presence of comorbidities and advanced patient age. Conclusions: Despite high heterogeneity, most studies in patients with MAC pulmonary disease document a five-year all-cause mortality exceeding 25%, indicating poor prognosis. These findings emphasise the need for more effective management and additional prospective mortality data collection. Electronic supplementary material: The online version of this article (10.1186/s12879-018-3113-x) contains supplementary material, which is available to authorized users. Twit Text FOAVip High mortality in patients with Mycobacterium avium complex lung disease: a systematic review ????BMC Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=29724184 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29724184 #FOAvip English Wikipedia <ref>{{Cite pmid|29724184}}</ref> High mortality in patients with Mycobacterium avium complex lung disease: a systematic review #MMPMID29724184 Diel R; Lipman M; Hoefsloot W BMC Infect Dis 2018[]; 18 (ä): ä PMID29724184show ga Background: The incidence of nontuberculous mycobacterial (NTM) pulmonary disease caused by Mycobacterium avium complex (MAC) in apparently immune-competent people is increasing worldwide. We performed a systematic review of the published literature on five-year all-cause mortality in patients with MAC lung disease, and pooled the mortality rates to give an overall estimate of five-year mortality from these studies. Methods: We systematically reviewed the literature up to 1st August 2017 using PubMedŽ and ProQuest Dialog? to search MedlineŽ and EmbaseŽ databases, respectively. Eligible studies contained >?10 patients with MAC, and numerical five-year mortality data or a treatment evaluation for this patient group. Mortality data were extracted and analysed to determine a pooled estimate of all-cause mortality. Results: Fourteen of 1035 identified studies, comprising 17 data sets with data from a total of 9035 patients, were eligible. The pooled estimate of five-year all-cause mortality was 27% (95% CI 21.3?37.8%). A high degree of heterogeneity was observed (I2 =?96%). The mortality in the data sets varied between 10 and 48%. Studies predominantly including patients with cavitary disease or greater comorbidity reported a higher risk of death. Patients in Asian studies tended to have a lower mortality risk. Predictors of mortality consistent across studies included male sex, presence of comorbidities and advanced patient age. Conclusions: Despite high heterogeneity, most studies in patients with MAC pulmonary disease document a five-year all-cause mortality exceeding 25%, indicating poor prognosis. These findings emphasise the need for more effective management and additional prospective mortality data collection. Electronic supplementary material: The online version of this article (10.1186/s12879-018-3113-x) contains supplementary material, which is available to authorized users. äHigh mortality in patients with Mycobacterium avium complex lung disea(epmc).pdf DeepDyve Pubget Overpricing